The article discusses a study based on randomized clinical trial (RCT) for assessing whether
magnesium sulphate given to women prior to preterm birth can protect their children against …

Please cite this paper as: Huusom L, Secher N, Pryds O, Whitfield K, Gluud C, Brok J.
Antenatal magnesium sulphate may prevent cerebral palsy in preterm infants—but are we …

TO THE EDITORS: The recent Cochrane Review 1 and similar metaanalysis by Conde-
Agudelo and Romero 2 establish a fetal neuroprotective role for antenatal magnesium …

Background Clinical practice guidelines recommend the use of antenatal magnesium
sulphate for fetal neuroprotection before preterm birth at< 30 weeks' gestation. Aims This …

Advances in perinatal and neonatal medicine have significantly improved survival rates of
preterm infants. This improvement has been associated with substantial risk of …

Background Magnesium sulfate is an accepted intervention for fetal neuroprotection. There
are some perceived differences in the international recommendations on the use …

Magnesium sulfate heptahydrate (MgSO4 7H2O), one of the most commonly used
medications in obstetrics, is an inorganic salt. It is manufactured by dissolution of kieserite in …

OBJECTIVE: To evaluate the association of duration of magnesium sulfate infusion with
stillbirth or death, cerebral palsy, and select adverse maternal and neonatal outcomes …

Objective Magnesium sulfate (MS) is standard of care for the prevention of moderate and
severe cerebral palsy (CP), among women who are expected to deliver at less than 32 …